🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Symptom Monitoring in Hemodialysis

RecruitingNAAges 18 Years - anyAllUniversity of Pennsylvania
NCT05738330 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The SMaRRT-HD trial is a cluster randomized trial of symptom monitoring with supported clinician follow-up using the SMaRRT-HD electronic patient reported outcome measure (ePROM) system versus Usual Care. Approximately 2400 patients at up to 36 geographically and racially diverse US hemodialysis clinics will be enrolled. The primary trial hypothesis is that regular symptom patient reported outcome measure (PROM) administration with supported clinician follow-up in dialysis care will reduce suffering and improve outcomes by prompting treatment of unrecognized symptoms, and enhancing patient-care team communication. Clinics randomized to the SMaRRT-HD group will adopt the use of SMaRRT-HD for 12 months. SMaRRT-HD is a symptom monitoring system that includes 1) tablet-based symptom reporting using a PROM and 2) supported clinician follow-up consisting of symptom alerts, guidances for sympto

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years * Treatment with hemodialysis at a participating dialysis clinic * English or Spanish speaking Exclusion Criteria: * Not willing to report their symptoms using the SMaRRT-HD platform * Not willing to share clinically acquired data with the research team * Underlying condition such as dementia that is anticipated to prevent comprehension of the trial information document (fact sheet) * Incarceration
💊

What it tests

  • Symptom Monitoring on Renal Replacement Therapy - Hemodialysis (SMaRRT-HD)
  • Usual Care
📍

Where

1 site
Fresenius Medical Care
Waltham, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy